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Abstract
Aim
This study aimed to assess intracellular Ca2+ dynamics in nerve cells and Schwann cells in isolated 
rat resistance arteries and determine how these dynamics modify noradrenaline release from the 
nerves and consequent force development.
Methods 
Ca2+ in nerves was assessed with confocal imaging, noradrenaline release with amperometry, and 
artery tone with wire myography. Ca2+ in axons was assessed after loading with Oregon Green 488 
BAPTA-1 dextran. In other experiments, arteries were incubated with Calcium Green-1-AM which 
loads both axons and Schwann cells. 
Results
Schwann cells but not axons responded with a Ca2+ increase to ATP. Electrical field stimulation of 
nerves caused a frequency dependent increase of varicose [Ca2+] ([Ca2+]v). ω-conotoxin-GVIA (100 
nM) reduced the [Ca2+]v transient to 2 Hz and 16 Hz by 60% and 27%, respectively; in contrast ω-
conotoxin GVIA  inhibited more than 80% of the noradrenaline release and force development at 2 
and 16 Hz. The KV channel blocker, 4-aminopyridine (10 µM), increased [Ca2+]v, noradrenaline 
release, and force development both in the absence and presence of ω-conotoxin-GVIA. Yohimbine 
(1 µM) increased both [Ca2+]v and noradrenaline release but reduced force development. 
Acetylcholine (10 µM) caused atropine-sensitive inhibition of [Ca2+]v, noradrenaline release and 
force. In the presence of ω-conotoxin-GVIA, acetylcholine caused a further inhibition of all 
parameters. 
Conclusion 
Modification of [Ca2+] in arterial sympathetic axons and Schwann cells was assessed separately. 
KV3.1 channels may be important regulators of [Ca2+]v, noradrenaline release, and force 
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development. Presynaptic adrenoceptor and muscarinic receptor activation modify transmitter 
release through modification of [Ca2+]v.
Keywords
Amperometry, confocal imaging, neurotransmission, prejunctional modulation, small arteries, 
sympathetic. 
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INTRODUCTION
Sympathetic nerves are important regulators of resistance artery tone. Extensive information on the 
pharmacology of transmitter release and transmitter effect in the vascular wall has accumulated 
over many years. This pharmacological characterization combined with evidence from other tissues 
suggest that the concentration of Ca2+ in the varicosities ([Ca2+]v) is important for transmitter 
release. It is also well known that several presynaptic receptors modify transmitter release and that 
pharmacological modification of ion channel activity can modify the release. Remarkably, however, 
there is no direct information on [Ca2+]v in the vascular sympathetic nerves and therefore no direct 
information as to whether, for example, presynaptic receptors or ion channel activity modify 
transmitter release through modification of [Ca2+]v. This is largely because the small size of the 
terminal branches of the sympathetic axons and the varicosities (which typically have diameters 
around 1 µm 1) and the presence of Schwann cells 1 make it difficult to directly assess [Ca2+]v and 
other second messengers in the varicosities.
In this study we have applied Ca2+-sensitive dyes, amperometry and myography to assess the 
relationship between [Ca2+]v, intracellular Ca2+ concentration ([Ca2+]i) in axons and Schwann cells, 
noradrenaline (NA) release, and force development in rat resistance arteries. Because we wanted to 
assess both [Ca2+]v in axons and [Ca2+]i in Schwann cells we used two calcium dye loading 
protocols.  To ensure selective dye loading of axons, we used a protocol developed for selective 
loading of axons in vas deferens 2-5. To load axons and Schwann cells simultaneously we used the 
traditional loading of a lipophilic Ca2+ sensitive dye. 
We have characterized the effect of known modulators of NA release on [Ca2+]v and related this to 
their effects on NA release and force development, and evaluated the differential effect of ATP on 
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[Ca2+]v and Schwann cell [Ca2+]i. We compared our [Ca2+]v data with [Ca2+]v data obtained in the 
sympathetic nerve terminals of vas deferens 2-5.
RESULTS
[Ca2+]i transients in nerve fibers loaded with Calcium Green-AM. 
Following loading of Calcium Green-AM, nerve fibers were easily seen (Fig. 1A) lying 
immediately outside the smooth muscle cells. The pattern seen after loading with Calcium Green-
AM was similar to the pattern seen after staining with the catecholamine-specific stain glyoxylic 
acid (Suppl. Fig 1) consistent with the structures stained with Calcium Green-AM are nerve fibers 
(i.e. axons and Schwann cells). It was not possible to distinguish varicosities. With field stimulation 
a frequency-dependent increase in [Ca2+]i was seen (Fig. 1B), which was TTX sensitive (insert Fig 
1B). At low frequencies the effect of individual stimuli could be discerned, and a cumulative 
increase of [Ca2+]i consequent to a slow net decrease of the [Ca2+]i transient was apparent (Fig. 1B). 
Where ≥3 nerve fibers crossed, the fluorescence was often bright (single arrow in Fig. 1A). In 20-
30% of these crossings, the nuclear stain Syto16 revealed the presence of nuclei in the nerve fiber 
(Fig. 1C, 1D and Suppl. Video 1). 
The increase of [Ca2+]i to 2 and 16 Hz stimulation is seen in nerve fibers (Fig. 1E) and in areas 
where nerve fibers cross (Fig. 1F) though the increase in [Ca2+]i at both 2 Hz and 16 Hz was small 
in areas where nerve fibers cross. Prior incubation with 10 µM ATP did not significantly increase 
the response to field stimulation in either of these areas (Fig. 1E and 1F). In non-activated arteries 
10 M ATP caused a substantial increase of [Ca2+]i in the area where nerve fibers cross (Fig. 2, 
column 2). In the nerve fibers outside the crossing areas the increase did not obtain statistical 
significance (Fig. 2, column 1).
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The increase in [Ca2+]i with field stimulation was partly inhibited by 100 nM of the N-type Ca2+ 
channel blocker ω-conotoxin GVIA (Fig. 3). The L-type Ca2+ channel blocker nifedipine (0.3 µM) 
and the predominantly T-type Ca2+ channel blocker mibefradil (1 µM) were without effect on 
[Ca2+]i (the fluorescence relative to the time control value were 1.02±0.02 and 1.01±0.01 for 
nifedipine and mibefradil, respectively, n=7). However, both 0.3 µM nifedipine and 1 µM 
mibefradil reduced the force response to stimulation with exogenous NA (with tension relative to 
the time control tension of 5±1% and 4±1% for nifedipine and mibefradil, respectively, n=7), 
indicating that they were used in relevant concentrations. The ω-conotoxin GVIA insensitive 
component of the [Ca2+]i response to field stimulation increased with increasing frequencies and 
only about 40% of the [Ca2+]i response to 16 Hz stimulation was inhibited by ω-conotoxin GVIA 
(Fig. 3). 
[Ca2+]i transients in axons loaded with Oregon Green 488 BAPTA-1 dextran 
In arterial segments loaded through the suction pipette with Oregon Green 488 BAPTA-1 dextran, 
varicosities and intervaricose segments were easily distinguished (Fig. 4A) while, as expected, 
extracellular structures, smooth muscle cells or endothelial cells were not seen. 
Field stimulation resulted in a frequency-dependent increase in [Ca2+]v (Fig. 4B). With Oregon 
Green 488 BAPTA dextran loading, the transient increase in [Ca2+]v to a single electrical pulse had 
a higher amplitude and a faster decline than the [Ca2+]i transient seen after Calcium Green-AM 
loading (Fig. 4C). The [Ca2+]v transients were fully inhibited by 100 nM TTX at all stimulation 
frequencies (data not shown).
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Addition of ATP caused a significant reduction of the [Ca2+]v amplitude to 2 Hz and 16 Hz (Fig. 
4D). In contrast to what was seen with Calcium Green AM loaded arteries, ATP did not increase 
baseline [Ca2+]v (Fig. 2, bar labeled Oregon Green).
Effect of pharmacological interventions on [Ca2+]v, noradrenaline release, and force
We assessed whether presynaptic pharmacological intervention modified NA release and force via 
an effect on [Ca2+]v. Fig. 5 shows traces from an experiment where NA release and force were 
assessed. Fig. 6 shows the mean values for the frequency-response curves for [Ca2+]v, NA release, 
and force. Based on these data it was decided to concentrate on stimulation with 2 Hz and 16 Hz. 
The drugs used in these experiments did not affect [Ca2+]v, NA, or force under baseline conditions 
(i.e. before the stimulation).
Ca2+ channel inhibition with ω-conotoxin GVIA. 
The effect of ω-conotoxin GVIA  on [Ca2+]v was frequency-dependent and a larger proportion of 
the [Ca2+]v response was inhibited at low frequencies compared to higher frequencies (Fig. 7A) 
similarly to what we observed for [Ca2+]i after Calcium Green AM loading. To assess whether 100 
nM ω-conotoxin GVIA was a supramaximal concentration, inhibition of [Ca2+]v transient with 100 
nM and 300 nM ω-conotoxin GVIA  was compared. No additional effect of 300 nM ω-conotoxin 
GVIA was seen (the response remaining to 16 Hz stimulation was 74±8% and 71±7% in the 
presence of 100 and 300 nM ω-conotoxin GVIA , respectively, n=4, n.s. paired Student t-test). In 
contrast 100 nM ω-conotoxin GVIA inhibited more than 80% of the NA release and force 
development (Fig. 7B and 7C) while having no effect on force development to exogenously applied 
NA (Fig. 8).
Page 7 of 33 Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
8
K+ channel inhibition. 
In the presence of 10 µM 4-AP, the field stimulation elicited [Ca2+]v transient, NA release and force 
development all increased (Fig. 7), while 10 µM 4-AP had no effect on force development to 
exogenously applied NA (Fig. 8). In the presence of -conotoxin GVIA, 4-AP still increased the 
responses (Fig. 7). To assess whether 10 µM 4-AP was sufficient to cause full effect, NA release 
and force at 16 Hz was assessed with 10 µM, 100 µM, and 200 µM 4-AP. The potentiation elicited 
with 100 µM 4-AP was greater than elicited with 10 µM 4-AP; with 200 µM 4-AP no further 
potentiation of NA release and force was seen (Fig. 9). The effect of 4-AP on tension development 
to 16 Hz was similar to the effect on NA release. To further characterize the K+-channels affected 
by 4-AP, the effects of charybdotoxin, TEA, and dendrotoxin were assessed. Charybdotoxin (100 
nM) had no effect on NA release (Fig. 9B) but potentiated the tension response to 16 Hz. TEA (0.5 
mM in the presence of charybdotoxin) increased the release of NA to the same extent as 100 µM 4-
AP. TEA at 1 and 2 mM caused a further increase in NA release. The effects of TEA on the tension 
response to 16 Hz was similar to the effect on NA release. Dendrotoxin (0.1µM) had no effect on 
field stimulation-induced force generation (2 Hz: 0.31±0.07 Nm-1 and 0.26±0.05 Nm-1 and 16 Hz: 
2.71±0.41 Nm-1 and 2.19±0.36 Nm-1, control and dendrotoxin, respectively (n=8 and 8). These 
experiments were made with 5.9 mM extracellular K+. We also determined the effect of 10 µM 4-
AP and 0.1 µM dendrotoxin at 3 mM K+. Also at the lower K+ concentration 4-AP increased the 
NA release to 16 Hz field stimulation (293±49 %, n=3), while dendrotoxin was without effect 
(126±28%, n=3).
-Adrenoceptor inhibition with yohimbine. 
In the presence of yohimbine (1 µM) [Ca2+]v and NA release increased (Fig. 7A and 7B) but force 
development was inhibited (Fig. 7C). In the presence of -conotoxin GVIA, yohimbine had no 
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effect on [Ca2+]v transients and NA release but did inhibit the force response at 16 Hz (Fig. 7). In 
the presence of 200 µM 4-AP or 2 mM TEA, yohimbine had no effect on NA release (Fig. 9) or 
tension response to 16 Hz. Yohimbine caused a rightward-shift of the concentration-force curve to 
exogenously applied NA (Fig. 8).
ACh receptor activation with ACh. 
ACh (20 µM) caused inhibition of [Ca2+]v, NA release and tension at both 2 Hz and 16 Hz (Fig. 7). 
In the presence of ω-conotoxin GVIA, ACh caused a further inhibition of [Ca2+]v, NA release and 
tension (Fig. 7). ACh caused a rightward shift of the concentration-force curve to exogenously 
applied NA (Fig. 8). The effects of ACh on NA release and force were prevented by application of 
1 µM atropine (n=4, data not shown).
DISCUSSION
Despite its critical importance for control of vascular tone no direct measurements have been made 
of the intravaricose signaling that leads to transmitter release or modifies transmitter release 
following depolarization of vascular sympathetic nerves. In this study we assessed Ca2+ transients in 
varicosities using a fluorescent dye technique that specifically loads axons of perivascular nerves. 
Using a different protocol for dye loading we also assessed Ca2+ transients in nerve fibers which 
include axons and Schwann cells. 
In one approach, we applied Calcium Green-AM, which is expected to load both Schwann cells and 
axons. In the second approach, we exposed the cut vessel ends to Oregon Green 488 BAPTA-1 
dextran. The latter technique exploits an axonal transport system present in nerves to transport the 
Page 9 of 33 Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
10
dye to downstream axons that have not been in direct contact with the dye.  Images in the 
downstream areas therefore reflect calcium in axons only. This was confirmed by several 
observations. Calcium Green-AM loading led to images of relatively thick nerves with a fuzzy 
appearance and with characteristic areas of high fluorescence intensity in areas where nerve fibers 
crossed. This contrasts with the sharply defined, thin fibers with distinct varicosities following 
Oregon Green 488 BAPTA-1 dextran loading. Staining with the nuclear dye Syto16 revealed that 
the areas of high Calcium Green fluorescence intensity often were contained nuclei. As cell nuclei 
present in nerve fibers are Schwann cell nuclei, our observations suggest that Schwann cell somas 
often locate to areas where nerve fibers cross. It will be relevant in further ultrastructural and 
stereological studies to test this conclusion. Additional evidence that the areas with high dye 
intensity are Schwann cells comes from the finding that ATP causes a substantial increase in [Ca2+]i 
in these areas while field stimulation causes only small increases in [Ca2+]i. The response to ATP 
confirms that the limited response to field stimulation in these areas is not due to dye saturation. 
Notably, ATP did not increase fluorescence when axons were loaded with Oregon Green 488 
BAPTA-1 dextran. Schwann cells in the sympathetic nerves respond to ATP with an increase of 
[Ca2+]i 6,7, so our data strongly suggests that Schwann cells take up Calcium Green-AM and that 
[Ca2+]i changes following intervention reflect Schwann cell function. We suggest that Schwann cell 
pharmacology can be assessed by imaging these areas following Calcium Green-AM loading. 
The Calcium Green-AM loaded nerves fibers outside the areas where nerve fibers cross responded 
with an increase of [Ca2+] to field stimulation in a frequency-dependent manner. Several 
observations suggest that these responses are dominated by the axons; 1) the responses were 
reminiscent of the response in the Oregon Green  488 BAPTA-1 dextran loaded arteries with minor 
quantitative differences (i.e. a slower transient), 2) the responses to electrical stimulation were small 
Page 10 of 33Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
11
in the areas of the putative Schwann cell body, 3) the N-type calcium channel blocker ω-conotoxin 
GVIA had similar effects in Oregon Green 488 BAPTA-1 dextran and Calcium Green-AM loaded 
arteries, 4) blockers of L-type and T-type calcium channels, which are expressed in Schwann cells 8 
were without effect in the Calcium Green-AM loaded arteries, and 5) the responses were TTX-
sensitive. 
Following Oregon Green 488 BAPTA-1 dextran loading the axons responded with a frequency-
dependent increase of [Ca2+]i. Both [Ca2+]i in the intervaricose segments and [Ca2+]v increased to 
field stimulation and the responses were fully inhibited with TTX, confirming their expected 
dependence on TTX-sensitive voltage-gated Na+ channels. 
N-type Ca2+ channel inhibition only partly reduced the Ca2+ increase in the axons. Even at low 
stimulation frequencies, when -conotoxin GVIA was most effective, a substantial part of the field 
stimulation-induced [Ca2+] increase remained. We routinely used 100 nM ω-conotoxin GVIA. 
Application of 300 nM did not cause any further inhibition of [Ca2+]v indicating that the remaining 
[Ca2+]v increase is unlikely to be via incompletely blocked N-type Ca2+ channels. A similar inability 
of ω-conotoxin GVIA to fully block the [Ca2+]v increase to field stimulation has been reported for 
vas deferens 2,4. We do not know which pathway is important for the remaining [Ca2+]v increase. 
Given that it was not blocked with nifedipine and mibefradil it is unlikely to be mediated by L-type 
and T-type calcium channels. In the vas deferens, Brain and Bennett (1997) found that the [Ca2+]v 
increase remaining after ω-conotoxin GVIA was also insensitive to 100 nM of the P/Q-type Ca2+ 
channel blocker, ω-agatoxin TK.  It will be important to determine the source of Ca2+ responsible 
for the ω-conotoxin GVIA -insensitive increase of [Ca2+]v and determine its physiological 
importance. In contrast to the effect of 100 nM ω-conotoxin GVIA on Ca2+, 100 nM ω-conotoxin 
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GVIA almost completely inhibited NA release and force development. This could suggest a steep 
relationship between [Ca2+]v and NA release. Against this possibility is the finding that in the 
presence of 4-AP and ω-conotoxin GVIA [Ca2+]v is very close to normal levels while NA release is 
substantially reduced. The alternative possibility, that a substantial part of the Ca2+ increase in the 
varicosities during field stimulation is irrelevant for NA release, is therefore more likely. 
The voltage-gated K+-channel inhibitor 4-AP is reported to increase transmitter release in the 
vascular wall 9,10. 4-AP is expected to modify the action potential and consequently enhance the 
[Ca2+]v increase; this has been observed with 10 mM 4-AP in the vas deferens 4. We found in the 
vascular wall that 10 µM 4-AP led to a significant increase of [Ca2+]v associated with an increase of 
NA release and force development. 4-AP not only increased the ω-conotoxin GVIA-sensitive 
component but also the ω-conotoxin GVIA-insensitive component, which suggests that the ω-
conotoxin GVIA-insensitive [Ca2+]v increase is controlled by the membrane potential and at least in 
part can contribute to NA release. At 10 µM, 4-AP had, as expected, no effect on the force 
development to exogenously applied NA, and the increased tension during field stimulation can be 
explained by the effect on NA release. The effect of 10 µM 4-AP on [Ca2+]v, NA release and force 
development is consistent with the finding that 10 µM 4-AP also increases 3H-noradrenaline 
overflow from the rabbit tail artery 10 and that 20 µM 4-AP blocks the endothelin-mediated 
inhibition of NA release from gastric nerves 11. Since 100 µM 4-AP produced a maximal effect, the 
KV3.1 channel, which is the only channel with an IC50 for 4-AP below 100 µM 12,13, is the most 
likely channel candidate. KV1 channels are suggested to be important in varicosities in vas deferens 
4, but KV1 channels have an IC50 for 4-AP of ≥160 µM 13 and are therefore less likely candidates in 
perivascular nerves. To further test the potential role of KV1 we used 100 nM dendrotoxin, which 
effectively blocks KV1 channels 13. The lack of effect of dendrotoxin further supports KV3.1 
channels as the most likely candidate. The effect of 4-AP and lack of effect of dendrotoxin was seen 
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at 5.9 mM extracellular K+ as well as the 3 mM K+ which is a more physiological K+ concentration. 
KV3.1 channels are sensitive to TEA at sub-mM concentrations 13. Our finding that 0.5 mM TEA 
enhanced NA release and force development to the same extent as 200 µM 4-AP further supports a 
role for KV3.1 channels. However, since 1 and 2 mM TEA had additional effects on NA release and 
force development, other K+-channels are likely to be important in the vascular varicosity: these are 
unlikely to be BKCa channels since charybdotoxin was without effect. 
Several presynaptic receptors modify transmitter release, although their mechanisms of action are 
not clear. We have assessed the signaling from cholinergic, adrenergic, and purinergic receptors. 
ACh caused a modest reduction of [Ca2+]v, particularly at 16 Hz, but a strong inhibition of NA 
release and force, mediated by muscarinic receptors. These effects were reminiscent of the effect of 
ω-conotoxin GVIA, and it seems likely that ACh works through inhibition of ω-conotoxin GVIA-
sensitive Ca2+ influx. However, ACh added in the presence of ω-conotoxin GVIA caused a further 
reduction of [Ca2+]v, suggesting that ACh may also partly decrease the ω-conotoxin GVIA-
insensitive increase of [Ca2+]v. The data reinforces the possibility that NA release can be modified 
through mechanisms independent of ω-conotoxin GVIA-sensitive Ca2+ influx. As expected, ACh 
also reduced force to exogenously applied NA, probably via an endothelium dependent mechanism. 
Therefore, the effect of ACh on field stimulation induced force development is difficult to interpret. 
Yohimbine, which is predominantly an 2-adrenoceptor antagonist, increased field stimulation-
induced [Ca2+]v increase and NA release, suggesting that presynaptic 2-adrenoceptor-mediated 
negative feedback of NA release signals through reduction of [Ca2+]v. Furthermore, since 
yohimbine had no effect on NA release in the presence of 4-AP or TEA, the presynaptic 2-
adrenoceptors most likely inhibits NA release via activation of KV3.1 channels. Despite the 
yohimbine induced potentiation of field stimulation-induced increase of [Ca2+]v and NA release, 
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yohimbine inhibited force development. Yohimbine also reduced the sensitivity to exogenously 
applied NA. This is despite the fact that smooth muscle cells of rat mesenteric small arteries only 
have 1-adrenoceptors 14, suggesting that 1 µM yohimbine may also inhibits 1-adrenoceptors in 
this preparation 15. We also found an inhibitory effect of ATP on the [Ca2+]v increase to field 
stimulation. It will be of interest to determine whether this is mediated via presynaptic P2Y 
receptors, as suggested for the sympathetic terminals of the mouse vas deferens 5.
Conclusion
In this study we have made a pharmacological characterization of Ca2+ homeostasis in varicosities 
and Schwann cells in the vascular wall and compared this to NA release and force development. We 
confirmed that Schwann cells respond with a [Ca2+]i increase to ATP. This contrast with 
varicosities, where a decrease of the [Ca2+]v transient to field stimulation is seen. Our data further 
suggests that a large part of the electrical field induced increase of [Ca2+]v is irrelevant for NA 
release. The pharmacological analysis suggests that KV3.1 is an important regulator of [Ca2+]v, NA 
release and force and suggest that both presynaptic adrenoceptors and muscarinic receptors modify 
transmitter release through effects on [Ca2+]v.
MATERIALS AND METHODS
Animals. Male Wistar rats (16-19 weeks) were used. The investigation conforms to the Guide for 
the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH 
Publication No. 85-23, revised 1996) as well as the guidelines from Directive 2010/63/EU of the 
European Parliament and Danish national guidelines for animal research. Rats were anesthetized 
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with CO2 inhalation and killed by decapitation. Branches (2nd and 3rd order) of the mesenteric artery 
were dissected out; the arteries had inner diameters of 200-250 µm.
Mounting and normalization of artery segments in myographs for isometric force recordings. For 
Ca2+ imaging 2-mm-long artery segments were mounted as rings in a myograph (360CW, Danish 
Myo Technology A/S, Denmark) for simultaneous recording of isometric force and confocal 
imaging as described previously 16. Force transducer readings were recorded at 100 Hz using 
PowerLab and LabChart (ADInstruments, New Zealand).
A passive tension-length curve was obtained and the arteries set, based on the passive tension-
length curve, to a value where near-maximal active force is developed 17. After equilibration in 
physiological salt solution (PSS; for composition see below) at 37°C for about 1 hour, the arteries 
were activated twice with 10 µM NA in PSS. The relaxed artery was then stimulated after one of 
several protocols. The basis for the protocols was a s ries of square-wave field stimulations from 
platinum electrodes placed in the mounting heads of the myograph as described previously 18. 
Stimulations were with electrical pulses with pulse width between 0.2 and 0.4 ms and a current 
strength of 40 mA. The pulses had frequencies from 0.5 to 16 Hz and were run for 3 s at each 
frequency. These frequencies were chosen because 1-2 Hz is the physiologically most relevant 
frequency19 and 16 Hz gives the maximal nerve-specific activation in this preparation20. An interval 
of 3 minutes was used between the different frequencies. In some protocols the arteries were 
stimulated only at 2 Hz and/or 16 Hz each for 3 s but otherwise using the same stimulation 
parameters. The arteries were incubated with drugs for 15 minutes before the electrical field 
stimulations were initiated. The drugs were used in the following concentrations: -conotoxin 
GVIA (CTX) 100 nM and 300 nM, 4-aminopyridine (4-AP) 10 µM, 100 µM, and 200 µM; 
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tetraethylammonium (TEA) 0.5 mM, 1 mM, and 2 mM; tetrodotoxin (TTX) 0.1 µM; dendrotoxin 
0.1 µM; charybdotoxin 0.1 µM; yohimbine 1 µM; ACh 20 µM and cocaine 3 µM. In some 
experiments, exogenous NA and ATP effects were assessed.
Loading of nerve fibers. After mounting and normalization of an artery segment in a myograph the 
artery was incubated with 5 µM of the Ca2+-sensitive dye Calcium Green-1-AM in PSS for two 
times 1.5 hours at 37°C.
Axon-specific loading. A 3-4 mm long artery segment was dissected. The proximal end of the artery 
was secured in a glass suction pipette filled with phosphate-free PSS (for composition see below) 
containing 43 mM Oregon Green 488 BAPTA-1 10 kDa dextran. The distal part of the artery was 
kept in PSS. The solution remained at room temperature and the segments were loaded for 5-6 
hours. Thereafter the artery was released from the glass suction pipette and maintained in PSS for a 
minimum of 3 hours at room temperature, after which the segment was mounted in a myograph as 
described above. 
Imaging. Imaging of Ca2+ in axons and nerve fibers was made with either a Noran Odyssey 
confocal unit mounted on a Nikon Inverted Microscope Eclipse TE2000-U with a 60×, water 
dipping objective or a Zeiss Axiovert 200M confocal microscope with a 40× water dipping 
objective. The excitation was from the 488 nm line of an argon laser, a dichroic mirror of 505 nm 
was used and on the emission side a bandpass filter of 515-555 nm was used. Time resolution was 
at least 4 images per second. 
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During Ca2+ imaging the PSS contained either 3 µM wortmannin or 1 µM -mATP and 0.2 µM 
prazosin which reduced contractions to field stimulation to less than 10% and consequently reduced 
movement artifacts. In these experiments 3 µM cocaine was present to inhibit NA uptake into the 
varicosities.
Loading and imaging cell nuclei with Syto16. To label nuclei the arteries mounted in the myograph 
were incubated with 1 µM Syto16 in PSS for 10 min at 37oC. After a wash in PSS, the arteries were 
imaged with the Zeiss confocal microscope with the settings used for Ca2+ imaging.
Measurement of NA release. In artery segments mounted in myographs for isometric force 
recording, NA release was measured using a MicroC™ Picoammeter/Potentiostat (WPI) with 
nafion coated carbon fiber electrodes (diameter 30 µm; length 1 mm), across which a potential of 
0.4 V was applied. The fiber electrodes were activated before use in accordance with the 
instructions from the company. After mounting the arteries in the myograph, the mounting heads 
and the artery were rotated to place the artery in a vertical position. Using a micromanipulator, the 
electrode was placed alongside the artery, with the electrode gently touching the artery as judged 
through the microscope. An Ag/AgCl electrode was used as reference electrode. Cocaine (3 µM) 
was present in all experiments. The signal was recorded simultaneously with force at 100 Hz. For 
calibration of the signal, NA was applied to the myograph chamber in increasing concentrations 
without an artery mounted in the myograph.
Solutions. PSS contained (in mmol L-1): NaCl 119, KCl 4.7, KH2PO4 1.18, MgSO4 1.17, NaHCO3 
25, CaCl2 1.6, EDTA 0.026, glucose 5.5, was gassed with 5% CO2 in air or 5% CO2/95% O2 
(during Oregon Green BAPTA-1 dextran loading) and had a pH of 7.4. In phosphate-free PSS 
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KH2PO4 was omitted. In low K+ solution KCl was reduced to 1.82 mM. ω-conotoxin GVIA was 
obtained from Alomone Labs (Jerusalem, Israel); 4-AP, yohimbine, NA, ACh, ATP, α,β-methylene 
ATP, TTX, prazosin, dendrotoxin, and charybdotoxin, and TEA were obtained from Sigma; cocaine 
was from Aarhus University Hospital. The Ca2+-sensitive dyes and Syto16 were obtained from 
Molecular Probes. Drug nomenclature is consistent with the Concise Guide to Pharmacology 21. 
During experiments the PSS was kept at 37°C.
Calculations and statistics. 
Fluorescence in regions of interest (ROIs) placed in nerve fibers was used for analysis in the 
Calcium Green-1-AM loaded arteries (5 to 10 ROIs per preparation) (Fig. 1A). In Oregon Green 
488 BAPTA-1 dextran-loaded arteries ROIs encompassed single varicosities or intervaricose 
segments (5 to 10 ROIs per preparation). 
Fluorescence intensity for ROIs was calculated as m an values of an interval of 3 s immediately 
before activation and for the last 1 s of the activation. The mean intensity from a ROI was obtained 
on all images of the stimulation series. Any movement of the ROI during the stimulation was 
corrected for by an automated procedure, written in MatLab, which tracked the varicosity between 
every frame based on the strongest local fluorescence signal compared with the background. 
Background values were obtained from ROIs immediately outside the nerves and subtracted from 
the values in the nerve specific ROIs. 
For each ROI, values during activation were expressed as the percentage of the value before 
activation, and the data for all ROIs in the image were averaged. No calibration of the fluorescence 
was made. The data obtained in the presence of CTX, 4-AP, yohimbine or ACh are expressed as the 
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percentage of the control values (i.e. without the drug) for individual ROIs and then averaged for 
the preparation. 
The analysis of NA concentration and force was performed in a similar manner, i.e. by obtaining a 
baseline value in a 3 s period before activation and the value during the last 1 s of the activation. 
The effects of drugs are expressed as percent of the baseline values. 
Statistical analyses were made with Student’s paired or unpaired t-test, two-way ANOVA, or extra 
sum-of-squares F-test as indicated. Data were expressed as mean±SEM, n is the number of arteries 
(one artery per rat) and p<0.05 was considered significant.
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LEGENDS TO FIGURES
Fig. 1.  A) Loading of nerve fibers in rat mesenteric small arteries with Calcium Green-AM.  The 
single arrow indicates an area of high dye intensity, where nerve fibers cross; the double arrow 
indicates area of lower dye intensity, which are nerve fibers. The red arrows indicate a smooth 
muscle cell, which is out of focus. Bar indicates 1 µm. B) Traces (typical of 5 experiments) 
showing the effect of field stimulation at increasing frequencies (in Hz: 0.5, blue; 1, red; 2, violet 4, 
green;16, light blue)  on [Ca2+] in nerve fibers (double arrow in fig. 1A).. The insert shows the 
effect of 0.1 µM tetrodotoxin (TTX) on 8 Hz field stimulation (typical of 3 experiments). C) and D) 
show two images of the same nerve fibers loaded with Calcium Green-AM  before (C) and after (D) 
staining with Syto16. An area of high Calcium Green intensity where several nerve fibers cross is 
seen. In 20-30% of these areas, Syto16 gave a strong fluorescence demonstrating the presence of a 
nucleus. Images are typical of 4 experiments. Bars indicate 1 µm. E) and F) Mean effect (n = 5) of 
field stimulation at 2 Hz and 16 Hz under control conditions (grey bars) and in the presence of ATP 
(hatched bars). In E nerve fibers (double arrow in fig. 1A), and in F areas where nerves cross (single 
arrow in fig. 1A) were imaged. There was no significant difference between control and ATP, two-
way ANOVA) for both E and F.
Fig. 2. The effect of 10 µM ATP on nerve fibers loaded with Calcium Green-AM (column 1 and 2) 
or axons loaded with Oregon Green 488 BAPTA-1 dextran. The response of nerve fibers (column 1; 
double arrow in fig. 1A) or areas with high dye load (column 2; single arrow in fig. 1A) to bath 
application of ATP was measured. * p<0.05; compared to fluorescence without ATP paired t-test; 
n=5. 
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Fig. 3. Effect of 100 µM ω-conotoxin GVIA on [Ca2+] in nerves as function of stimulation 
frequency in Calcium Green-AM loaded arteries. The responses to field stimulation are given as the 
percentage of the response at respective frequency in the absence of ω-conotoxin GVIA, n=6.
 
Fig. 4. A) Image of axons in rat mesenteric small arteries loaded with Oregon Green 488 BAPTA-1 
dextran; bar indicates 1 µm. B) Traces showing the effect of field stimulation at increasing 
frequencies (in Hz: 0.5, blue; 1, red; 2, violet 4, green;16, light blue) on [Ca2+]v in Oregon Green 
488 BAPTA-1 dextran loaded axons.  C) Traces showing the effect of a single pulse on Calcium 
Green-AM loaded nerve fibers (black trace) and Oregon Green 488 BAPTA-1 dextran loaded axons 
(violet). D) The effect of 10 µM ATP on [Ca2+]v transients to field stimulation at 2 and 16 Hz in 
axons.  * p<0.05; control vs. ATP two-way ANOVA, n=5.
Fig. 5. Traces of noradrenaline release (top) and forc  (bottom) of rat mesenteric artery to field 
stimulation with frequencies of 2 Hz and 16 Hz under control conditions and in the presence of 10 
µM 4-aminopyridine. 
Fig. 6. The average effect of field stimulation on [Ca2+]v (Oregon Green 488 BAPTA-1 dextran) (A, 
n=14), noradrenaline (NA) release (B, n=16), and force (C, n=16). The data plotted in B and C were 
recorded simultaneously from the same preparations. Data are given as the percentage of the 
response at 16 Hz.
Fig. 7. Effects of 100 nM ω-conotoxin GVIA (CTX), 10 µM 4-aminopyridine (4-AP), 1 µM 
yohimbine (Yoh), and 20 µM acetylcholine (ACh) on [Ca2+]v (Oregon Green 488 BAPTA-1 
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dextran loaded axons) (A), noradrenaline release (B), and force (C) during 2 and 16 Hz stimulation 
of rat mesenteric small arteries. The hatched bars are the responses in the presence of CTX. 
Responses are given as the percentage of the responses of the same preparations at respective 
frequency in the absence of drugs.  * p<0.05; paired t-test; different from 100 % (i.e. significant 
effect of the drug); @ p<0.05; unpaired t-test; different from the response in the presence of CTX 
alone (i.e. effect of the drug in the presence of CTX); n=3-8. 
Fig. 8. Effects of 100 nM ω-conotoxin GVIA (A, n=5), 10 µM 4-AP (B, n=5), 1 µM yohimbine (C, 
n=5) and 20 µM ACh (D, n=5) on force development to exogenously applied noradrenaline. E 
shows time-control (two consecutive concentration-response relationships obtained from the same 
preparation, n=4. The responses were obtained in the presence of 3 µM cocaine and given as the 
percentage of the maximum response. * p<0.05; extra sum-of-squares F-test. 
 
Fig. 9. Effect of 4-aminopyridine (4-AP), charybdotoxin, tetraethylammonium (TEA), and 
yohimbine on 16 Hz field stimulation-induced noradrenaline release and tension development. A) 
n=10; B) n=8. The columns represent cumulative addition of the drugs. * p<0.05; paired t-test.
Suppl. Fig. 1. Staining of nerve fibers with Calcium Green-AM (A) and glyoxylic acid (B) in rat 
mesenteric small arteries. In A cell nuclei are stained with Syto16. The preparation in A is shown as 
a 3D structure in Suppl. Video 1. In Suppl. video 1 note that the nucleus marked with a double 
arrow in (A) is in the nerve fiber, whereas the nucleus marked with a single arrow in (A) is outside 
the nerve fiber. Bar indicates 4 µm.
Suppl. Video 1. A rat mesenteric small artery stained with Calcium Green-AM An image stack is 
obtained with confocal microscopy and presented as a 3-D image.
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